New Parallels Between Parkinson’s Disease and MPTP-Induced Parkinsonism in the Monkey

This publication has 9 references indexed in Scilit:

• Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density
  Brain Research, 1986
• Initiation of Levodopa Therapy in Parkinsonian Patients Should Be Delayed Until the Advanced Stages of the Disease
  Archives of Neurology, 1986
• Chronic low‐dose levodopa therapy in Parkinson's disease
  Neurology, 1984
• [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
  European Journal of Pharmacology, 1984
• Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s Disease
  Canadian Journal of Neurological Sciences, 1984
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
  Proceedings of the National Academy of Sciences, 1983
• Dopamine receptors in the parkinsonian brain
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
• Analysis of the clinical problems in parkinsonism and the complications of long‐term levodopa therapy
  Neurology, 1979
• Neurotransmitter receptor alterations in Parkinson's disease
  Life Sciences, 1977